Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
لماذا يهم هذا الخبر؟
سيظهر الملخص التحليلي هنا بعد اكتمال معالجة الذكاء الاصطناعي.
سياق الخبر
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
فتح الخبر الأصلي